One Device, Four Definitions: How FDA, MDR, Health Canada, and TGA Classify a Home IPL

We build home IPL devices for brands that sell them across the US, Europe, Canada, Australia, and beyond. Every time a brand adds a new market, the first question is always the same. What do they call this thing over there, and what does that mean for the certification.

The honest answer is that the device does not change. The handset is the same quartz lamp, the same filter, the same skin tone sensor. What changes is the name each regulator gives it, and that name decides the whole compliance path. Get the name wrong and you budget for the wrong certification, or worse, you launch and get pulled.

This article lines up the definitions from the regulators that matter most, in their own terms. If you are sourcing an IPL line and planning which markets to enter, this is the map.

The United States, FDA

The FDA gives the home IPL device the most precise label in the business. It is a light based over-the-counter hair removal device, product code OHT, regulated under 21 CFR 878.4810 as a Class II device. The pathway is 510(k), not PMA.

The definition is worth reading closely, because it is exact about what the device actually does. It uses thermal energy to kill hair follicles for hair removal. The target is skin, including the dermis and epidermis, the underlying soft tissue, and the hair follicles. The review panel is General and Plastic Surgery.

A few facts from the FDA entry matter for anyone budgeting a launch. The device is subject to GMP, so the manufacturer needs a quality system in place. It is neither implanted nor life sustaining. Malfunction reporting is eligible, which means a real post-market surveillance obligation exists.

The FDA also names the recognized consensus standards, and this is where it gets useful. The list is almost entirely about photobiological safety. IEC 62471 for photobiological safety of lamps and lamp systems. Three ANSI IES RP-27 standards covering measurement techniques, general requirements, and risk group classification. A home IPL is, at the regulatory level, a lamp pointed at skin, and the standards all flow from that.

The whole entry is searchable in the FDA database, which is the point we always make to clients. A device either has a verifiable 510(k) number or it does not, and the database settles it.

The European Union, MDR

Europe is the market where the definition has shifted most recently. The Medical Device Regulation, MDR 2017/745, took over from the old Medical Device Directive in May 2021, and it changed how a home IPL gets classified.

The key difference is a concept called Annex XVI. These are products without an intended medical purpose, and a home hair removal device falls under it. The European Commission has been working through a reclassification of exactly these beauty devices, and the direction is tighter, not looser. A device that used to sit in a gray area is now pulled into the medical device framework.

Under MDR, the home IPL is treated as an active device, and it generally lands in Class IIa under classification rule 9, which covers active therapeutic devices. The practical consequence is that a CE mark under the old directive is no longer enough. A brand entering Europe now needs a notified body involved, a technical file built to MDR, and a quality system that survives an audit.

The regulation itself is public and readable on EUR-Lex. The short version for a brand owner is that Europe got more expensive and more rigorous, and the days of a self-declared beauty device are over for this category.

The IEC boundary, home versus professional

There is one definition that does not come from a country regulator, and it is the cleanest boundary of all. It comes from the IEC, the body that writes the electrical safety standards, through the CB Scheme.

The CB Scheme is a mutual recognition system. A product is tested once against an IEC standard, the test lab issues a CB certificate, and other countries accept that certificate as the basis for their own national mark. It does not replace the national registration. It replaces the need to re-test in every country.

For a home IPL device, the standard that applies is IEC 60335-2-113, the particular requirements for household beauty care appliances that use light. The standard for professional or medical light devices is IEC 60601-2-57, for non-laser light source equipment. The IEC states the boundary in its own notes. Home-use appliances are covered by IEC 60335-2-113.

That single sentence is the whole answer to the home versus medical question. Its classification follows who uses it and where. A consumer using it at home puts it under the household appliance standard. A professional using it in a clinic puts it under the medical standard. The photobiological safety side, IEC 62471, applies to both, because light on skin is light on skin.

For a brand, this means one more file to get right. The test report for IEC 60335-2-113 is the document that unlocks electrical safety acceptance in most markets, and it is one a manufacturer should already hold before you ever ask for it.

Canada, Health Canada

Canada regulates the home IPL through Health Canada, and a device needs a Medical Device License, an MDL, before it can be sold. The classification runs on the same broad logic as the FDA. A home IPL is a Class II medical device, and the license is the gate.

The detail that keeps coming up with Canadian clients is skin tone sensing. Health Canada expects the device to handle the risk of darker skin safely, and the skin tone sensor is the mechanism. We covered this in the skin tone sensor article, but the short version is that Canada treats the sensor as a safety necessity, not a feature.

The practical path is the same as the US in spirit. A quality system, a technical file, and an application to Health Canada. The difference is the paperwork, and the fact that an FDA clearance does not carry over. Each market wants its own file.

Australia, TGA

Australia routes the home IPL through the Therapeutic Goods Administration, and the device has to be listed on the Australian Register of Therapeutic Goods, the ARTG, before it can be sold. The TGA is its own jurisdiction with its own sponsor system, and an overseas manufacturer needs an Australian sponsor to hold the registration.

The classification again tracks the same logic as the US and Canada. It is a Class II medical device, and the entry on the ARTG is the thing to check. A brand that has done the FDA work is most of the way there, because the technical file and the test data carry over, but the registration itself is separate and must be done.

Japan, the tricky one

Japan is the market where the definition genuinely splits, and it is the one brands get wrong most often. A home IPL device can sit on either side of a line. On one side it is a medical device under the Pharmaceuticals and Medical Devices Act, which means the PMDA route. On the other side it is a household beauty appliance, which means the electrical safety route through PSE and different advertising rules.

Where a specific device lands depends on how it is marketed and what it claims. A device that promises hair removal at the follicle level reads as medical. A device positioned as a beauty appliance sits closer to the appliance side. The Japanese rules on advertising are strict, and the phrase you use in the listing can pull the device across the line.

This is the market where we tell clients to get a local regulatory opinion before committing, because the same handset can need two entirely different files depending on how the brand wants to sell it. The other markets disagree on details. Japan disagrees on the category itself.

MDSAP, the shortcut across several of them

MDSAP — the Medical Device Single Audit Program — is an audit scheme that sits underneath the regulators, and it is what makes the four definitions above less painful. One audit, done against the MDSAP framework, is accepted by the US FDA, Health Canada, the TGA, Brazil’s ANVISA, and Japan’s PMDA.

For a brand entering three or four of those markets, MDSAP collapses what would be three or four separate audits into one. It does not remove the need to file in each market. It removes the need to sit through a separate audit for each. For a manufacturer building for several of those markets, one shared quality framework across them is what makes the certification burden lighter for the brands it serves.

The naming convention, a small thing that means a lot

One more definition layer matters here, and it lives on the box: how the device is named. A home IPL with contact cooling is listed as an Ice Cooling IPL Hair Removal Device. A device without it is listed as a plain IPL Hair Removal Device.

That prefix is not decorative. Ice cooling is the feature that changed the category, because it is the thing that makes treatment painless enough for people to keep using the device. The name tells the buyer which generation of device they are looking at, and it tells a brand what the market now expects. A new IPL line without cooling is competing at a disadvantage before the customer even opens the box.

Who files what, and what the manufacturer hands over

A common confusion is who actually applies for these certifications. The split is simple once you see it.

The market entry registrations are filed in the customer’s country, and often by the brand or a local representative on the brand’s behalf. The FDA 510(k) is filed by whoever owns the device, which is usually the manufacturer or the brand depending on the deal. The Canadian MDL, the Australian ARTG, the Saudi MDMA, and the Japanese route are filed with a local sponsor or authorized representative in that country. The brand, as the one selling there, is the one that has to hold or arrange that local registration.

What the manufacturer hands over is everything that sits underneath the filing. The technical file. The test reports, which means the IEC 60335-2-113 report, the IEC 62471 photobiological report, and the biocompatibility data. The quality system certificate, ISO 13485. The risk management file. The label and the instructions for use. The bill of materials and the raw material declarations for RoHS and REACH.

The practical way to think about it is that the manufacturer provides the evidence, and the brand or the local partner files the application on top of that evidence. A manufacturer that has done this before can hand over a folder that is already most of the application.

What it costs, in numbers

Cost is the question everyone asks last and should ask first. The figures are converted to US dollars so you can compare everything on one line. Where a number is not posted publicly and depends on the market and the notified body, we mark it as quote on request rather than inventing a figure.

Certification	Official fee (USD)	Local third party, customer side (USD)	Chinese manufacturer, led (USD)
FDA 510(k)	24,000 to 29,000	50,000 to 100,000	quote on request, usually lower
EU MDR	quote on request	quote on request	quote on request
Health Canada MDL	460 to 470 (CAD 632 to 643)	quote on request	quote on request
Australia TGA ARTG	780 to 820 application + 810 to 860 annual (AUD)	quote on request	quote on request
SFDA Saudi MDMA	4,000 to 6,130 (SAR 15,000 to 23,000)	2,000 AR + 4,000 MDMA (SAR)	quote on request
CB certification	quote on request	quote on request	1,490 to 4,480 (RMB 10,000 to 30,000), rough range

The two numbers worth staring at are Canada and Australia. A Class II medical device licence in Canada costs under five hundred US dollars. An ARTG application in Australia costs under a thousand, with a similar annual charge on top. The government fee is the smallest line. The testing, the consulting, and the local sponsor retainer are where the money actually goes, and those are quoted case by case.

The FDA is the exception, and it is a big one. The user fee alone is twenty four to twenty nine thousand dollars, and a full program through a Western firm lands between fifty and a hundred thousand. That is why the FDA market gets planned carefully before anyone spends.

The SFDA numbers come from an actual quotation we hold for a Saudi authorized representative, converted at 3.75 SAR to the dollar. The authorized representative retainer is two thousand dollars a year. An MDMA filing is four thousand dollars, with the government fee on top, from four thousand for Class A up to six thousand for Class D.

The CB figure is a range, ten to thirty thousand RMB in a Chinese lab, which is roughly fifteen hundred to forty five hundred dollars at 6.70. We mark it as a rough range because CB is quoted per project, not posted, and the spread depends on the lab and the device.

The one honest generalization that survives all of this. A Chinese manufacturer that already holds the technical file, the test reports, and the ISO 13485 system starts from a file that exists, and the Chinese certification industry is mature and competitive. That route is almost always cheaper than having a Western firm build the file from your spec sheet, because most of the work is already done. The tradeoff is unchanged. The brand still needs the local registration in the customer’s country, and that part never moves.

What this means for a brand

The through-line across every market is the same. The device is a light based, thermally active, Class II or equivalent medical device, and every regulator wants the same three things. A quality system, a technical file, and proof that the light is photobiologically safe.

The differences are procedural. The FDA wants a 510(k). Europe wants a notified body and MDR compliance. Canada wants an MDL. Australia wants an ARTG listing. Japan wants you to decide whether you are a medical device or an appliance, and then file accordingly.

None of this is a reason to avoid a market. It is a reason to plan the market before you plan the certification, because the definition you need is the one the target market writes, not the one on your spec sheet. We build the device once. The regulators describe it four different ways, and a brand that learns all four names before it spends anything is the one that launches without a surprise.

---

Sources: FDA product classification, code OHT, MDR 2017/745, Health Canada medical devices, TGA ARTG, MDSAP, IEC 62471.